Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 145
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Living Skin Therapeutics

One of the biggest roadblocks to having clear skin is acne, and despite all the effective treatment options...

Can a Meal Replacement Help Solve Hunger in America?

In the United States, hunger is commonplace. 42 million Americans struggle to get the healthy foods they need...

Does Zika virus replicate in neural cells?

Zika virus is a rapidly emerging virus that is spreading throughout the Western Hemisphere. It is predicted...

Backer Badge Funded